Liying Guan

470 citations
17 papers · 263 indexed · h-index 10
Topics
Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers)Liver Disease Diagnosis and Treatment (3 papers)Alcohol Consumption and Health Effects (3 papers)
Partner nations
China

In The Last Decade

Liying Guan

17 papers receiving 260 citations

Peers

Liying Guan
Comparison fields: 5 of 71
  • Endocrinology, Diabetes and Metabolism 150
  • Epidemiology 106
  • Cardiology and Cardiovascular Medicine 40
  • Physiology 40
  • Molecular Biology 31
Replace Marissa Lightbourne with:
Marissa Lightbourne United States
Lini Dong China
Enrique Soto‐Pedre United Kingdom
Metaxia Tampourlou Greece
Minerva Granado-Casas Spain
Miao Xu China
Won Seon Jeon South Korea
Claudia Colombi Italy
Adelina Tsakova Bulgaria
Liying Guan relative to Marissa Lightbourne United States Marissa Lightbourne's profile →
Citations per field
00.5×1.5×2.0×
Marissa Lightbourne · 1×
Citations per year

Countries citing papers authored by Liying Guan

Since Specialization
Citations

This map shows the geographic impact of Liying Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liying Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liying Guan more than expected).

Fields of papers citing papers by Liying Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liying Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liying Guan. The network helps show where Liying Guan may publish in the future.

Co-authorship network of co-authors of Liying Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Liying Guan. A scholar is included among the top collaborators of Liying Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liying Guan. Liying Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 14
5 6
6 17
7 25
8 10
9 4
10 8
11 4
12 73
13 19
14 13
15 27
16 13
17 27

About Liying Guan

Liying Guan is a scholar working on Endocrinology, Diabetes and Metabolism, Occupational Therapy and Rheumatology, having authored 17 papers that have together received 263 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Alcohol Consumption and Health Effects (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (150 citations), Epidemiology (106 citations) and Occupational Therapy (10 citations). Liying Guan has collaborated with scholars based in China. Frequent co-authors include Qingbo Guan, Qiu Li, Qian Wang, Xu Zhang, Haiyan Lin, Yibing Wang, Xiaohong Li, Yumei Liu, Xiaoyan Jiang and Haiyan Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026